精品国产一区二区桃色

Member News

Orth, Tu, van der Donk receive HHMI pathogen awards

ASBMB Today Staff
April 24, 2023

The Howard Hughes Medical Institute has announced that 精品国产一区二区桃色 members Kim Orth, Wilfred van der Donk and Benjamin Tu are among the 70 researchers who will receive awards as part of the HHMI’s Emerging Pathogens Initiative. These awards fund research to prepare for infectious diseases that could threaten human health. 

Kim Orth
Benjamin Tu
Wilfred van der Donk

Orth will receive $7 million over three years to work with a team of four assistant professors to identify fast-evolving virulence factors from clinically relevant pathogens. Tu and his team will receive $9.5 million over three years to research natural products that could be used to fight emerging pathogens. van der Donk and his team will receive $9.5 million over three years to research the avian and human antibody response to emerging influenza viruses. 

is a professor of molecular biology and biochemistry at the University of Texas Southwestern Medical Center. Her lab focuses on the basic biochemical mechanisms that underlie bacterial infections with a focus on how bacteria such as Vibrio parahaemolyticus hijack and deregulate cellular signaling. Orth was elected to the National Academy of Sciences in 2020. She is an ASBMB fellow and won the 2019 ASBMB-Merck Award and the society’s 2012 Young Investigator Award. 

is a professor of biochemistry at UT Southwestern. His lab investigates how cellular processes such as cell growth and division, transcription, translation, mitochondrial homeostasis and autophagy coordinate the metabolic state of the cell. He was recently awarded the Edith and Peter O’Donnell Award by the Texas Academy of Medicine, Engineering Science & Technology. Tu is a co-chair of the 2024 ASBMB annual meeting, Discover BMB, to be held in San Antonio.

is a professor of chemistry at the University of Illinois Urbana-Champaign. His lab uses synthetic organic chemistry and molecular biology to study enzymatic transformations with implications for the environment and pharmaceuticals. van der Donk was recently elected to the National Academy of Sciences. He served as a co-chair of the 2018 ASBMB annual meeting. 

HHMI is committing $100 million to this initiative to support basic research targeted at preparedness for emerging pathogens. 

“With this program, we hope to gain some of the knowledge and tools we need to get a scientific head start on future epidemics.” HHMI Vice President and Chief Scientific Officer Leslie Vosshall said in a .

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Ralph G. Yount
In Memoriam

In memoriam: Ralph G. Yount

July 28, 2025

He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
Profile

From dust to discovery

July 23, 2025

From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.